Magdelenat H
Pathol Biol (Paris). 1983 Nov;31(9):755-60.
The assays of estrogen (ER) and even more progesterone (PR) receptors are highly required to elaborate the therapeutic strategy adapted to every breast cancer. In order to get this information in the absence of surgery (conservative treatment), three types of tissue sampling are available: drill-biopsy, "thru-cut", and fine needle aspiration. Reliable estimates of ER or PR can be obtained on drill-biopsy or "thru-cut" samples in about 80% of breast tumors measuring more than 2 cm. Fine-needle aspiration allows, up to now, only ER assay, in about 80% of all breast tumors.
为制定适用于每例乳腺癌的治疗策略,对雌激素(ER)受体甚至孕激素(PR)受体进行检测极为必要。为在不进行手术(保守治疗)的情况下获取此类信息,有三种组织取样方法可供选择:钻孔活检、“穿刺活检”和细针穿刺抽吸。对于直径超过2厘米的约80%的乳腺肿瘤,通过钻孔活检或“穿刺活检”样本可获得可靠的ER或PR检测结果。截至目前,细针穿刺抽吸仅能对约80%的所有乳腺肿瘤进行ER检测。